Prescription Drug News and Research

RSS

Lawmakers examine how Medicare, Medicaid can help stop prescription painkiller abuse

Lawmakers held a hearing Thursday on what steps the federal government can take to help prevent the abuse of prescription painkillers.

23 Mar 2012

The health law officially turns two -- now what?

Supporters are marking the health law's second birthday today even as questions swirl about whether it will get to celebrate a third. Meanwhile, media outlets examine where implementation stands and what is yet to come.

23 Mar 2012

Md. launches health reform website for consumers; Calif. public option lives on

Maryland is launching a health care reform website to educate residents on how they can use benefits in the health law. In California, health reform already affects most residents while the state gets set to offer a version of its own "public option" to buy health insurance.

23 Mar 2012

First Edition: March 23, 2012

Today's health policy headlines are full of previews of next week's health law action at the Supreme Court.

23 Mar 2012

The health law's second anniversary: Where do things stand?

As the sweeping overhaul turns two and the Supreme Court prepares to review its constitutionality, news outlets report on what provisions have taken effect, what changes are still in the pipeline and how people have been affected so far.

23 Mar 2012

Lawmakers allege some drug companies inflate cost of scarce drugs with 'fake pharmacies'

Rep. Elijah Cummings, D-Md., is leading a congressional investigation accusing some drug distributors of opening "fake pharmacies" to drive up the cost of some pharmacueticals that are in short supply.

23 Mar 2012

Hyperion acquires worldwide rights to Ucyclyd's Ravicti

Hyperion Therapeutics, Inc. today announced that it has acquired worldwide rights to the investigational drug Ravicti from Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation.

23 Mar 2012

Study shows gender gap in medication management

Women use more prescription drugs than men; yet they are not prescribed proper amounts. In a new study presented at Women's Health 2012: The 20th Annual Congress by Medco Health Solutions, Inc. and the Society for Women's Health Research (SWHR) women are prescribed more drugs than men, have poorer adherence rates to using the drugs than men, and, perhaps most surprisingly, lag behind men in receiving the appropriate drugs for their documented diseases.

22 Mar 2012

Marking the health law's second anniversary

News outlets report on what the future holds as the health law turns 2. Meanwhile, the Department of Health and Human Services steps up its messaging related to the measure's benefits.

21 Mar 2012

PSG closes acquisition of Artemetrx

Pharmaceutical Strategies Group, LLC, America's largest independent pharmacy benefits consulting firm, has closed on its acquisition of Artemetrx Health Resources, the company announced today.

21 Mar 2012

Argus to participate in National Council for Prescription Drug Programs focus group

Argus Health Systems Inc., a leading transparent pharmacy benefits administrator, will participate in a National Council for Prescription Drug Programs (NCPDP) focus group on March 20, 2012, to better understand the growing biopharmaceuticals industry.

17 Mar 2012

The Medical Letter introduces mobile apps for iPad, Android

The Medical Letter – recognized since 1959 as the most trusted source of unbiased prescription drug information and drug facts - announces the launch of its mobile apps for iPad, iPhone, iPod Touch and Android.

17 Mar 2012

Repligen total revenue increases to $7,165,000 for quarter ended December 31, 2011

Repligen Corporation today reported financial results for the quarter and nine-month fiscal year ended December 31, 2011.

17 Mar 2012

New drug approval pathway to encourage development of critically needed, lifesaving antibiotics

Congress will consider a new drug approval pathway to encourage development of critically needed, lifesaving antibiotics as part of a strategy to address the public health crisis of antibiotic resistance. The Infectious Diseases Society of America (IDSA) proposed the new pathway, the "Special Population Limited Medical Use (SPLMU)" mechanism, to provide an important new approval option for companies interested in developing drugs to treat patients with serious infections where few or no treatment options exist.

10 Mar 2012

Get ready for Be Medicinewise Week 2012

Building on the success of last year’s inaugural event, the week will urge all Australians to stop, think and learn more about the medicines they are using and encourage them to seek information to make better decisions about their health.

8 Mar 2012

Australian TGA approves Bayer's EYLEA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.

8 Mar 2012

FDA accepts Eisai's resubmission of perampanel NDA for review

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's resubmission of the New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy.

5 Mar 2012